Growth Metrics

Ekso Bionics Holdings (EKSO) Depreciation & Amortization (CF) (2016 - 2026)

Ekso Bionics Holdings has reported Depreciation & Amortization (CF) over the past 13 years, most recently at $451000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 13.32% to $451000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 2.18% decrease, with the full-year FY2025 number at $1.6 million, down 2.18% from a year prior.
  • Depreciation & Amortization (CF) reached $451000.0 in Q4 2025 per EKSO's latest filing, up from $367000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $451000.0 in Q4 2025, with the low at -$221000.0 in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $377500.0 (2025), against an average of $291350.0.
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 22200.0% in 2021, then skyrocketed 23000.0% in 2022.
  • Tracing EKSO's Depreciation & Amortization (CF) over 5 years: stood at -$221000.0 in 2021, then skyrocketed by 216.74% to $258000.0 in 2022, then skyrocketed by 67.44% to $432000.0 in 2023, then dropped by 7.87% to $398000.0 in 2024, then increased by 13.32% to $451000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $451000.0, $367000.0, and $377000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.